Controversies in primary CNS lymphoma Journal Article


Author: Abrey, L. E.
Article Title: Controversies in primary CNS lymphoma
Abstract: Primary CNS lymphoma is a non-Hodgkin's lymphoma confined to the CNS: the brain, eyes and cerebrospinal fluid. Unlike other primary brain tumors, primary CNS lymphoma is uniquely chemo- and radiosensitive. However, the outcome of primary CNS lymphoma patients is significantly inferior to similar non-Hodgkin's lymphoma patients. Multiple prospective studies using high-dose methotrexate, with or without whole-brain radiotherapy, have reported improved primary CNS lymphoma outcome, but numerous questions remain regarding the optimal care of a given patient. © 2005 Future Drugs Ltd.
Keywords: treatment outcome; clinical trial; review; cancer recurrence; doxorubicin; drug penetration; antineoplastic agents; cancer radiotherapy; radiation dose; chemotherapy; cytarabine; ibritumomab tiuxetan; methotrexate; rituximab; temozolomide; drug megadose; molecular genetics; neurotoxicity; brain tumor; antineoplastic agent; carboplatin; cancer immunotherapy; etoposide; radiotherapy; cyclophosphamide; dexamethasone; melphalan; vincristine; stem cell transplantation; chemosensitivity; carmustine; ifosfamide; lomustine; procarbazine; thiotepa; central nervous system tumor; central nervous system neoplasms; monoclonal antibody; patient care; prednisolone; nonhodgkin lymphoma; immunotherapy; cerebrospinal fluid; lymphoma, non-hodgkin; urine incontinence; dementia; radiosensitivity; methylprednisolone; primary cns lymphoma; corticosteroid; drug dose regimen; teniposide; gait disorder; eye tumor; cerebrospinal fluid level; cholesterol oxidase; thiosulfate
Journal Title: Expert Review of Neurotherapeutics
Volume: 5
Issue: 4
ISSN: 1473-7175
Publisher: Informa Healthcare  
Date Published: 2005-07-01
Start Page: 459
End Page: 464
Language: English
DOI: 10.1586/14737175.5.4.459
PUBMED: 16026229
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 24 October 2012" - "CODEN: ERNXA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lauren E Abrey
    278 Abrey